Cardiovascular protective effects of GLP-1: a focus on the MAPK signaling pathway
- 1 February 2022
- journal article
- review article
- Published by Canadian Science Publishing in Biochemistry and Cell Biology
- Vol. 100 (1), 9-16
- https://doi.org/10.1139/bcb-2021-0365
Abstract
Cardiovascular and related metabolic diseases are significant global health challenges. Glucagon-like peptide 1 (GLP-1) is a brain-gut peptide secreted by ileal endocrine that is now an established drug target in type 2 diabetes (T2DM). GLP-1 targeting agents have been shown not only to treat T2DM, but also to exert cardiovascular protective effects through regulating multiple signaling pathways. The mitogen-activated protein kinase (MAPK) pathway, a common signal transduction pathway for transmitting extracellular signals to downstream effector molecules, is involved in regulating diverse cell physiological processes, including cell proliferation, differentiation, stress, inflammation, functional synchronization, transformation and apoptosis. The purpose of this review is to highlight the relationship between GLP-1 and cardiovascular disease (CVD), and discuss how GLP-1 exerts cardiovascular protective effects through MAPK signaling pathway. This review also discusses the future challenges in fully characterizing and evaluating the CVD protective effects of GLP-1 receptor agonists (GLP-1RA) at the cellular and molecular level. A better understanding of MAPK signaling pathway that are disregulated in CVD may aid in the design and development of promising GLP-1RA.Keywords
This publication has 82 references indexed in Scilit:
- The Ras-ERK pathway modulates cytoskeleton organization, cell motility and lung metastasis signature genes in MDA-MB-231 LM2Oncogene, 2013
- Mitogen-activated protein kinases in innate immunityNature Reviews Immunology, 2013
- Impact of Diabetes on Cardiovascular Disease: An UpdateInternational Journal of Hypertension, 2013
- Predicted structure of agonist-bound glucagon-like peptide 1 receptor, a class B G protein-coupled receptorProceedings of the National Academy of Sciences of the United States of America, 2012
- Molecular Mechanisms of Cardiotoxicity Induced by ErbB Receptor Inhibitor Cancer TherapeuticsInternational Journal of Molecular Sciences, 2012
- Cardiovascular Biology of the Incretin SystemEndocrine Reviews, 2012
- Pathological roles of MAPK signaling pathways in human diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- GLP-1R Agonist Liraglutide Activates Cytoprotective Pathways and Improves Outcomes After Experimental Myocardial Infarction in MiceDiabetes, 2009
- Mechanisms of Cardiac Dysfunction Associated With Tyrosine Kinase Inhibitor Cancer TherapeuticsJournal of the American College of Cardiology, 2008
- Role of Smooth Muscle Cells in the Initiation and Early Progression of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2008